Clinical Trial Update: Mycophenolic Acid Monotherapy in Recipients of HLA-identical Living-Related Transplantation [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating mycophenolic acid monotherapy in recipients of HLA-identical living-related kidney transplants; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Mycophenolic acid (mycophenolic acid)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Kidney Transplantation | Phase 2 | Status: TERMINATED | Results posted: 2019-07-05